Table 4.
Univariate and Cox model analyses of the disease-specific survival in the 674 patients.
| Variables | Univariate | Cox model | |
|---|---|---|---|
| p | p | HR[95% CI] | |
| Age (<40 vs. ≥40) | 0.231 | ||
| Sex (Male vs. female) | 0.156 | ||
| Smoker | <0.001 | <0.001 | 1.336 [1.075–1.748] |
| Drinker | 0.374 | ||
| Primary site | |||
| Tongue + The mouth floor vs. others | <0.001 | <0.001 | 2.132 [1.426–3.164] |
| Pathologic tumor stage | |||
| T3+T4 vs. T1+T2 | <0.001 | <0.001 | 3.128 [1.476–5.129] |
| Tumor differentiation | |||
| Moderate + poor vs. well | <0.001 | <0.001 | 2.006 [1.387–3.814] |
| Perineural invasion | <0.001 | <0.001 | 2.061 [1.337–3.994] |
| Lymphovascular invasion | <0.001 | <0.001 | 2.116 [1.452–3.860] |
| Neck lymph node stage | <0.001 | ||
| N0 | |||
| N1 | <0.001 | 1.456 [1.027–1.999] | |
| N2 | <0.001 | 2.375 [1.564–3.555] | |
| N3 | <0.001 | 3.467 [2.622–5.932] | |
| Number of lymph node examined | |||
| <22 vs. ≥22 | 0.513 | ||
| HPV positivity | 0.673 | ||
| p16 positivity | 0.024 | <0.001 | 1.321 [1.048–1.733] |
| Positive margin | <0.001 | <0.001 | 3.776 [1.671–5.997] |
| Number of positive lymph nodes | <0.001 | ||
| 0 | |||
| 1-2 | <0.001 | 1.862 [1.122–2.442] | |
| 3-4 | <0.001 | 3.189 [2.611–4.554] | |
| ≥5 | <0.001 | 6.316 [4.673–10.227] | |